ClearPoint Neuro Inc. (CLPT) Insider Trading

Last 12 months

Insiders sold $2.47M and bought nothing on the open market.

90% of the selling was scheduled in advance under 10b5-1 plans. Director Matthew B. Klein sold $185k on May 21, 25% of their stake, outside a plan. The last open-market buy by an executive or director was in Sep 2018.

Net open-market

−$2.47M

0 buys · 8 sales

Under a 10b5-1 plan

90%

of the value sold

Insiders who bought / sold

0 / 4

executives and directors

Last open-market buy

Sep 2018

Sep 25, 2018

Get an email when CLPT's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jun 29	Joseph Burnett CEO and President	Sold10b5-1 plan	20,000	$19.38	$388k	6.1%	Form 4
Jun 17	Joseph Burnett CEO and President	Sold10b5-1 plan 2 parts	61,843	$17.79 average	$1.1M	17%	Form 4
Jun 1	Timothy T. Richards Director	SoldNo plan	5,415	$12.17	$66k	5.8%	Form 4
May 21	Matthew B. Klein Director	SoldNo plan	16,000	$11.59	$185k	25%	Form 4
May 20	Lynnette C Fallon Director	Sold10b5-1 plan	5,091	$11.14	$57k	9.5%	Form 4
Feb 25	Joseph Burnett CEO and President	Sold10b5-1 plan	19,951	$15.17	$303k	8.8%	Form 4
Jan 26	Joseph Burnett CEO and President	Sold10b5-1 plan	2,943	$15.57	$46k	1.3%	Form 4
Jan 9	Joseph Burnett CEO and President	Sold10b5-1 plan	20,000	$16.12	$322k	8.0%	Form 4
Oct 10, 2025	Joseph Burnett CEO and President	Sold10b5-1 plan 4 parts	26,463	$26.98 average	$714k	10%	Form 4
Jun 10, 2025	Timothy T. Richards Director	SoldNo plan	10,000	$13.28	$133k	11%	Form 4
Jun 9, 2025	Joseph Burnett CEO and President	SoldNo plan	21,247	$13.29	$282k	7.3%	Form 4
Jun 3, 2025	Lynnette C Fallon Director	SoldNo plan 2 parts	10,200	$12.57 average	$128k	20%	Form 4

Jun 2910b5-1 plan
Joseph Burnett
CEO and President · sold 20,000 at $19.38
$388k
6.1% of stake
Jun 1710b5-1 plan
Joseph Burnett
CEO and President · sold 61,843 at avg $17.79
$1.1M
17% of stake
Jun 1No plan
Timothy T. Richards
Director · sold 5,415 at $12.17
$66k
5.8% of stake
May 21No plan
Matthew B. Klein
Director · sold 16,000 at $11.59
$185k
25% of stake
May 2010b5-1 plan
Lynnette C Fallon
Director · sold 5,091 at $11.14
$57k
9.5% of stake
Feb 2510b5-1 plan
Joseph Burnett
CEO and President · sold 19,951 at $15.17
$303k
8.8% of stake
Jan 2610b5-1 plan
Joseph Burnett
CEO and President · sold 2,943 at $15.57
$46k
1.3% of stake
Jan 910b5-1 plan
Joseph Burnett
CEO and President · sold 20,000 at $16.12
$322k
8.0% of stake
Oct 10, 202510b5-1 plan
Joseph Burnett
CEO and President · sold 26,463 at avg $26.98
$714k
10% of stake
Jun 10, 2025No plan
Timothy T. Richards
Director · sold 10,000 at $13.28
$133k
11% of stake
Jun 9, 2025No plan
Joseph Burnett
CEO and President · sold 21,247 at $13.29
$282k
7.3% of stake
Jun 3, 2025No plan
Lynnette C Fallon
Director · sold 10,200 at avg $12.57
$128k
20% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch CLPT, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Surgical & Medical Instruments & Apparatus

KRMDKoru Medical Systems Inc.

SNWVSanuwave Health Inc.

TLSITriSalus Life Sciences Inc.

UTMDUtah Medical Products Inc.

CTSOCytosorbents Corporation

RVPRetractable Technologies Inc.

IDXGInterpace Biosciences Inc.

SSIISS Innovations International, Inc.

Spot a number that looks wrong? Check it in CLPT's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing CLPT

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.